Eisai Cuts US Leqembi Sales Forecast But Japan, China Exceed Expectations

Infusion Center Access Becomes Bottleneck

I.V. infusion center capacity has become a roadblock to Leqembi access in the US (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Scrip